224 related articles for article (PubMed ID: 12769689)
1. Tumor angiogenesis: a potential target in cancer control by phytochemicals.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2003 Jun; 3(3):205-17. PubMed ID: 12769689
[TBL] [Abstract][Full Text] [Related]
2. Anti-angiogenesis Potential of Phytochemicals for the Therapeutic Management of Tumors.
Munir S; Shah AA; Shahid M; Ahmed MS; Shahid A; Rajoka MSR; Akash MSH; Akram M; Khurshid M
Curr Pharm Des; 2020; 26(2):265-278. PubMed ID: 31886747
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors. Drug selectivity and target specificity.
Kesisis G; Broxterman H; Giaccone G
Curr Pharm Des; 2007; 13(27):2795-809. PubMed ID: 17897024
[TBL] [Abstract][Full Text] [Related]
4. [Novel angiogenesis inhibitors for molecular target therapy of cancer].
Osada H; Kakeya H
Nihon Rinsho; 2004 Jul; 62(7):1257-63. PubMed ID: 15283141
[TBL] [Abstract][Full Text] [Related]
5. Evading tumor evasion: current concepts and perspectives of anti-angiogenic cancer therapy.
Abdollahi A; Folkman J
Drug Resist Updat; 2010; 13(1-2):16-28. PubMed ID: 20061178
[TBL] [Abstract][Full Text] [Related]
6. Tumor angiogenesis--a potential target in cancer chemoprevention.
Bhat TA; Singh RP
Food Chem Toxicol; 2008 Apr; 46(4):1334-45. PubMed ID: 17919802
[TBL] [Abstract][Full Text] [Related]
7. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
8. Inducible nitric oxide synthase-vascular endothelial growth factor axis: a potential target to inhibit tumor angiogenesis by dietary agents.
Singh RP; Agarwal R
Curr Cancer Drug Targets; 2007 Aug; 7(5):475-83. PubMed ID: 17691907
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic targeting of angiogenesis molecular pathways in angiogenesis-dependent diseases.
Fallah A; Sadeghinia A; Kahroba H; Samadi A; Heidari HR; Bradaran B; Zeinali S; Molavi O
Biomed Pharmacother; 2019 Feb; 110():775-785. PubMed ID: 30554116
[TBL] [Abstract][Full Text] [Related]
10. The critical role of vascular endothelial growth factor in tumor angiogenesis.
Amini A; Masoumi Moghaddam S; Morris DL; Pourgholami MH
Curr Cancer Drug Targets; 2012 Jan; 12(1):23-43. PubMed ID: 22111836
[TBL] [Abstract][Full Text] [Related]
11. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
12. Molecular regulation of tumor angiogenesis: mechanisms and therapeutic implications.
Harper J; Moses MA
EXS; 2006; (96):223-68. PubMed ID: 16383021
[TBL] [Abstract][Full Text] [Related]
13. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand".
Rak J; Yu JL
Semin Cancer Biol; 2004 Apr; 14(2):93-104. PubMed ID: 15018893
[TBL] [Abstract][Full Text] [Related]
14. [Angiogenesis and antiangiogenic cancer therapy].
Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
[TBL] [Abstract][Full Text] [Related]
15. Discovery and validation of drug targets for tumour angiogenesis.
Kremmidiotis G; Lavranos TC
Expert Opin Ther Targets; 2005 Apr; 9(2):211-5. PubMed ID: 15934910
[TBL] [Abstract][Full Text] [Related]
16. Drug inhibition of angiogenesis.
Madhusudan S; Harris AL
Curr Opin Pharmacol; 2002 Aug; 2(4):403-14. PubMed ID: 12127873
[TBL] [Abstract][Full Text] [Related]
17. Targeting Metabolism to Counteract Tumor Angiogenesis: A Review of Patent Literature.
Petrillo S; Tolosano E; Munaron L; Genova T
Recent Pat Anticancer Drug Discov; 2018; 13(4):422-427. PubMed ID: 29807523
[TBL] [Abstract][Full Text] [Related]
18. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
19. Optimization of vascular-targeting drugs in a computational model of tumor growth.
Gevertz J
Phys Rev E Stat Nonlin Soft Matter Phys; 2012 Apr; 85(4 Pt 1):041914. PubMed ID: 22680505
[TBL] [Abstract][Full Text] [Related]
20. Targeting the tumor vascular compartment to improve conventional cancer therapy.
Feron O
Trends Pharmacol Sci; 2004 Oct; 25(10):536-42. PubMed ID: 15380938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
